The Week in Review: July 27 – August 24, 2018

Friday, August 24, 2018 News Recap: Neuropsychiatric symptoms in hepatitis C patients resemble those of patients with autoimmune liver disease but are different from those in hepatitis B patients. Chronic fatigue, mood alterations and cognitive impairment are frequent accessory symptoms of HCV-infection. Fatigue and mood alterations have also been observed in autoimmune hepatitis (AIH) and primary biliary cholangitis (PBC), but not in hepatitis B vi...

New online calculator predicts clinical improvement in liver failure after Hep C treatment

Investigators formulated a five-factor metric known as the BE3A score that offers specialists a shared decision-making tool to predict potential improvements after treatment in patients with hepatitis C virus (HCV)-associated liver failure, as detailed in a new study published in Gastroenterology. The five factors in the BE3A score include body mass index (BMI), encephalopathy, ascites, and serum levels of both alanine aminotransferase (ALT) and albumin.

The Week in Review: March 16 – March 23, 2018

Friday, March 23, 2018 News Recap: Northern Vancouver Island VIRAL HEPATITIS Outreach Roadshow Trip 2018 SlideShow.  Our team of volunteers has just return from a week of outreach on Vancouver Island’s north end, and we have put together few slideshows to tell you the story. There will be more images in the next few days, but check out what we have so far! A heartfelt thanks to Cheryl, Leon and Rosemary for doing this. Novel score predicts DAA ben...

Novel score predicts DAA benefit in patients with HCV, decompensated cirrhosis

Researchers have developed a predictive score that quantifies the potential benefits of direct-acting antiviral therapy for patients with hepatitis C and decompensated cirrhosis, according to recently published data. Five factors – BMI, hepatic encephalopathy, ascites, serum albumin and alanine aminotransferase levels – contribute to the novel BE3A score. “There are certain hepatitis C medications that you cannot use in patients with decompensation becaus